Ironwood Pharmaceuticals ...

NASDAQ: IRWD · Real-Time Price · USD
1.04
-0.03 (-2.80%)
At close: Aug 15, 2025, 3:59 PM
1.08
3.85%
After-hours: Aug 15, 2025, 05:20 PM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-32.34M 880K -2.46M 7.84M -1.08B -1.03B -980.95M -944.58M 181.98M 175.06M 167.57M 173.1M 527.32M 528.45M 530.28M 508.86M 142.76M
Depreciation & Amortization
1.98M 2.01M 2.04M 2.04M 1.8M 1.57M 1.4M 1.26M 1.35M 1.42M 1.44M 1.43M 1.47M 1.52M 1.58M 3.05M 3.29M
Stock-Based Compensation
26.76M 29.85M 33.99M 33.56M 33.26M 32.01M 30.59M 29.75M 28.09M 27.05M 25.85M 24.99M 22.97M 22.28M 26.2M 27.7M 30.21M
Other Working Capital
-16.99M -26.29M 4.47M -8.71M -7.63M -11.63M -17M -6.46M -5.16M 2.94M 14.18M 11.51M 8.34M 529.89M 517.08M 515.23M 513.2M
Other Non-Cash Items
2.18M 1.98M 6.49M 6.72M 1.07B 1.07B 1.07B 1.06B 1.57M 992K 9.29M 12.99M 18.4M 24.41M 21.42M 23.08M 22.67M
Deferred Income Tax
62.71M 68.09M 58.31M 64.88M 61.63M 72.64M 61.45M 63.2M 68.08M 65.74M 47.54M 34.1M -315.42M -332.5M -334.85M -334.76M 744K
Change in Working Capital
17.24M 739K 25.81M 31.69M 35.25M 11.28M 21.96M 21.79M 8.06M 2.82M 6.78M 17.84M -2.42M 17.73M 4.21M -521K -742K
Operating Cash Flow
78.52M 103.55M 124.17M 146.74M 148.24M 183.43M 226.78M 263.41M 289.81M 273.76M 259.15M 265.12M 252.32M 261.89M 248.84M 227.41M 198.93M
Capital Expenditures
-121K -158K -353K -386K -328K -273K -35K -52K -140K -136K -291K -362K -274K -265K -165K -28K -404K
Cash Acquisitions
n/a n/a -3.98M -26.55M -1.03B -1.03B -1.02B -999.49M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-121K -158K -4.33M -26.94M -1.03B -1.03B -1.02B -999.54M -140K -136K -291K -362K -274K -265K -165K -28K -404K
Debt Repayment
25M n/a -125M -175M 275M 300M 325M 400M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -33.9M -126.39M -150.53M -150.53M -116.63M -24.13M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-116.42M -117.03M -29.8M -27.64M -28.45M -23.85M 5.86M 6.66M -108.8M -111.16M -132.55M -127.19M -5.14M -4.55M 17.56M 12.07M 8.8M
Financial Cash Flow
-91.41M -106.97M -142.99M -190.82M 257.62M 277.16M 330.87M 406.65M -142.7M -237.55M -258.95M -253.58M -97.63M -4.55M 17.56M 12.07M 8.8M
Net Cash Flow
-13.06M -3.6M -23.25M -71.09M -620.54M -565.78M -464.46M -329.48M 146.97M 36.07M -88K 11.18M 154.42M 257.08M 266.24M 239.45M 207.32M
Free Cash Flow
78.41M 103.41M 123.82M 146.36M 147.91M 183.15M 226.74M 263.36M 289.67M 273.63M 258.86M 264.76M 252.05M 261.63M 248.68M 227.38M 198.52M